US Biotechnology Company: The CoronaVirus Vaccine Is Ready For Humans Clinical Trial
The 'mRNA-1273' vaccine to combat the COVID-19 Corona Virus is ready to be tested on humans.
Image Souece Pixabay By Pete Linforth
Trials for a CoronaVirus vaccine can begin in late April, antihydrogen offers clues about the antimatter mystery of great material and a powerful tool for synthetic biologists.
The vaccine has been sent to the National Institute of Allergy and Infectious Diseases (NIAID) in Bethesda, Maryland.
I think this is the first trial of a CoronaVirus vaccine in humans, the first results are expected as desired.
"This is a new record, entering the first phase of the trial in just three months. Nothing has ever run that fast,"
The impact of the vaccine trial caused Moderna's stock price to rise 19% on February 25, 2020, to around USD22 per share. Is the news really like that?
I think this will attract the attention of other drug makers too, competing to develop vaccines against the CoronaVirus, including Sanofi, Inovio Pharmaceuticals, Novavax and Johnson & Johnson.
Indeed, as we know, the CoronaVirus is too dangerous to be officially known as COVID-19, which has infected more than 80,000 people and killed nearly 3,000 people.
@hive-157940, thank you for supporting @steemitboard as a witness.
Click on the badge to view your Board of Honor.
Once again, thanks for your support!
@tipu curate
Upvoted 👌 (Mana: 10/15 - need recharge?)
Ehm. That's quite a short post @hive-157940 :/
I am surprised at the speed of production and that they gave such quick permission for human testing.
I suppose the conspiracy theorists would say that it is proof that it is a disease created in the laboratory and that the purpose is to create a market and raise the values of the actions of pharmacological companies, in addition to hitting the Chinese economy.